ATAD2 and breast carcinoma: Encouragingly, a recent study found that AM879, an inhibitor of ATAD2, blocks the PI3K-AKT-mTOR pathway through ATAD2 inhibition, thereby facilitating breast cancer cell apoptosis and autophagy-associated cell death 89.